Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1446113-23-0
2. 31m3wlj3kg
3. 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide
4. Gdc-5573
5. 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide
6. Hm95573
7. 4-amino-n-{1-[(3-chloro-2-fluorophenyl)amino]-6-methylisoquinolin-5-yl}thieno[3,2-d]pyrimidine-7-carboxamide
8. 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno(3,2-d)pyrimidine-7-carboxamide
9. Belvarafenib [inn]
10. Unii-31m3wlj3kg
11. Belvarafenib [who-dd]
12. Chembl3977543
13. Schembl15066408
14. Gtpl11544
15. Bdbm185591
16. Bcp31233
17. Ex-a3061
18. Whc11323
19. S8853
20. Akos037648828
21. Ac-36878
22. Bs-15746
23. Example 116 [wo2013100632a1]
24. Hy-109080
25. Cs-0039257
26. D81081
27. Belvarafenib(gdc5573, Hm95573, Rg6185)
28. A930123
29. Us9156852, 116
30. 4-amino-n-(1-(3-chloro-2-fluorophenylamino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide
31. Thieno(3,2-d)pyrimidine-7-carboxamide, 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methyl-5-isoquinolinyl)-
32. V1y
Molecular Weight | 478.9 g/mol |
---|---|
Molecular Formula | C23H16ClFN6OS |
XLogP3 | 4.9 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 478.0778862 g/mol |
Monoisotopic Mass | 478.0778862 g/mol |
Topological Polar Surface Area | 134 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 708 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
36
PharmaCompass offers a list of Belvarafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Belvarafenib manufacturer or Belvarafenib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Belvarafenib manufacturer or Belvarafenib supplier.
PharmaCompass also assists you with knowing the Belvarafenib API Price utilized in the formulation of products. Belvarafenib API Price is not always fixed or binding as the Belvarafenib Price is obtained through a variety of data sources. The Belvarafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Belvarafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Belvarafenib, including repackagers and relabelers. The FDA regulates Belvarafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Belvarafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Belvarafenib supplier is an individual or a company that provides Belvarafenib active pharmaceutical ingredient (API) or Belvarafenib finished formulations upon request. The Belvarafenib suppliers may include Belvarafenib API manufacturers, exporters, distributors and traders.
Belvarafenib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Belvarafenib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Belvarafenib GMP manufacturer or Belvarafenib GMP API supplier for your needs.
A Belvarafenib CoA (Certificate of Analysis) is a formal document that attests to Belvarafenib's compliance with Belvarafenib specifications and serves as a tool for batch-level quality control.
Belvarafenib CoA mostly includes findings from lab analyses of a specific batch. For each Belvarafenib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Belvarafenib may be tested according to a variety of international standards, such as European Pharmacopoeia (Belvarafenib EP), Belvarafenib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Belvarafenib USP).